TrialEuropean urology2019

Clinical and Biological Characterisation of Localised High-risk Prostate Cancer: Results of a Randomised Preoperative Study of a Luteinising Hormone-releasing Hormone Agonist with or Without Abiraterone Acetate plus Prednisone.

Eleni Efstathiou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.